Ireland’s HSE Faces Renewed Calls for Action Following NHS Deal for Critical Spinal Muscular Atrophy Drug
Free-Photos / Pixabay

Ireland’s HSE Faces Renewed Calls for Action Following NHS Deal for Critical Spinal Muscular Atrophy Drug

According to a story from thejournal.ie, Ireland's Health Services Executive (HSE) is facing renewed pressure from activists and patient advocates for a reasonable coverage decision regarding Spinraza, which is currently…

Continue Reading Ireland’s HSE Faces Renewed Calls for Action Following NHS Deal for Critical Spinal Muscular Atrophy Drug

Could This Revised Genetic Test Improve Diagnostic Rates for Familial Hypercholesterolemia?

According to a story from Healio, a recent study suggests that the addition of four more genes to the conventional genetic test used to diagnosed familial hypercholesterolemia could allow more…

Continue Reading Could This Revised Genetic Test Improve Diagnostic Rates for Familial Hypercholesterolemia?

Phase 3 Trial Results Continue to Show the Efficacy of Orencia as a Treatment for Juvenile Idiopathic Arthritis

Orencia Orencia (abatacept) is a treatment for juvenile idiopathic arthritis (JIA) that was approved for use in the U.S. for the pediatric patient population in 2008. In Japan, the therapy…

Continue Reading Phase 3 Trial Results Continue to Show the Efficacy of Orencia as a Treatment for Juvenile Idiopathic Arthritis